Navigation Links
Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Date:2/26/2008

LA JOLLA, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) received permission from Argyll Biotechnologies, LLC to release before and after wound healing photographs resulting from subcutaneous injections of the biopharmaceutical SF-1019 from the first phase of a formal "Proof of Concept Trial" which has been successfully completed in Europe for treatment of Diabetic Ulcers with SF-1019.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080226/LATU104)

The primary purpose of the "Proof of Concept Trial" is to further evaluate the safety and efficacy of SF-1019 in the treatment of Diabetic Ulceration and its effect on Diabetic Polyneuropathy in Type 1 Diabetes Mellitus by both subcutaneous injection and by topical application. The first phase, which is now complete, involved an extremely small cohort of patients.

"Seldom is it possible to demonstrate the efficacy of a biopharmaceutical such as SF-1019 in a media that people can actually see," said Stephen D. Ferrone, President and CEO of Immunosyn. "Photographic evidence such as this is indeed significant."

The images seen below as well as additional images are also available for viewing at http://www.immunosyn.com/du-beforeandafter.html. A specialized grid referenced Polaroid camera was used for photographic documentation in order to prevent digital manipulation and to substantiate authenticity of the images.

"This first very important phase in the development of SF-1019, which was undertaken at a European venue by Argyll Biotechnologies, has indicated that SF-1019 promotes wound healing and almost certainly induces growth factors. When systemically delivered (subcutaneously), SF-1019 has shown the resolution of long standing chronic lesions which is very impressive," stated Professo
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
2. Immunosyn Corporation Releases SF-1019 Study Results
3. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
6. CEL-SCI Corporation Releases Letter to Shareholders
7. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
8. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
9. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
10. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
11. Treatment of First Patient in Phase I Clinical Trial of Bionomics Anti-Cancer Drug BNC105
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ... Healthcare, Regulatory and Reimbursement Landscape Poland " an ... trends in the healthcare market and provides insights ... infrastructure. Most importantly, the report provides valuable insights ...
(Date:8/28/2014)... BURLINGTON, Mass. , Aug. 28, 2014  Decision Resources ... will remain constant, at around $7.7 billion by 2023 in ... , Germany , Italy ... United Kingdom and Japan . ... KGaA,s Erbitux will be balanced out by the launch of ...
(Date:8/28/2014)...   Edison Nation Medical , the premier ... for product ideas to improve the health and ... through the 6-month search ( www.EdisonNationMedical.com/Seniors ) will ... healthcare retailers with whom Edison Nation Medical has ... 65 and older. The objective of ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... RIDGE, N.J. , March 15 Regado Biosciences, ... aptamers with active control agents, announced that Chris Rusconi ... Steven Zelenkofske , DO, FACC, Senior Vice President , Chief ... Cardiology on Monday, March 15, 2010 in ...
... SAN FRANCISCO, Calif. , March 15 Poniard ... on innovative oncology therapies, today announced the sale of 4,229,000 ... Fund, Ltd. for gross proceeds of approximately $6.3 million ... existing committed equity financing facility with Commerce Court.  Poniard intends ...
Cached Medicine Technology:Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 2Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 4Poniard Pharmaceuticals Announces $6.3 Million Financing 2Poniard Pharmaceuticals Announces $6.3 Million Financing 3Poniard Pharmaceuticals Announces $6.3 Million Financing 4
(Date:8/29/2014)... The 8th Annual Paint Columbus Pink® is a series ... Pooch Contest, Light of Life Ceremony, Power in Prayer, Bright ... – all in support of cancer awareness. , Paint Columbus ... Columbus Pink Foam and Obstacle Challenge on Saturday, October 4th, ... Columbus, Georgia 31904. It will be the first foam and ...
(Date:8/29/2014)... Canada Older adults who stay active by volunteering ... altruistic feeling they are receiving a health boost! ... Rotman Research Institute at Baycrest Health Sciences and published ... the first to take a broad-brush look at all ... of formal volunteering for older adults. , Lead investigator ...
(Date:8/29/2014)... After having a double mastectomy due ... have breast reconstruction. She found that the look of ... that there needed to be a solution. , The ... or man who needs or wants breast improvements. It's ... and peace of mind. Producible in design variations, the ...
(Date:8/29/2014)... August 29, 2014 Honey Gifts, premium ... company will now be selling purse-sized adult toys and ... way that they can be carried in a woman’s ... the purse-sized range at Honey Gifts is also leak-free ... life and rechargeable batteries are common characteristics of Honey ...
(Date:8/29/2014)... 2014 University of Western States (UWS), ... announced that Daniel Redwood, DC, director of the human ... the Year,” by the Missouri State Chiropractors Association (MSCA) ... , Patrick Montgomery, DC, president of the MSCA, cited ... Missouri House Task Force for Medicaid Reform, in bringing ...
Breaking Medicine News(10 mins):Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2
... Dec. 1 America,s pharmaceutical research companies are testing ... related conditions, according to a report released today by the ... marks the 20th anniversary of "World AIDS Day" - a ... of Ministers of Health on Programmes for AIDS Prevention. , ...
... Early discussion with your orthopaedic surgeon is the driving force ... , ROSEMONT, Ill., Dec. 1 /PRNewswire-USNewswire/ ... any musculoskeletal injury may be anxious to get back into ... the wheel of a car can be a difficult and ...
... Deadline Is December 31st , , ... D annual enrollment period is nearly halfway over - running from ... is an opportunity for seniors to change the prescription drug program ... in a Part D plan to enroll. , ...
... Unmet Needs for HIV Prevention, Calls on Governments to Increase ... (Para tener acceso a una copia completa de ... , , WASHINGTON, Dec. 1 ... women and Latina women in the United States is demanding ...
... 1, 2008 -- 11 a.m. news event -- Hall of ... DC 20001 , , WASHINGTON, ... coming together to outline the current fiscal situation states are ... a recovery package that will spur job growth, support infrastructure ...
... DISCOVERY IN MOLECULAR IMAGING , , ... North America (RSNA) honored Ralph Weissleder, MD, PhD, with its ... one scientist who has made original significant contributions to the ... is Professor at Harvard Medical School , as well ...
Cached Medicine News:Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 2Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 3Health News:When to Get Back Behind the Wheel While on the Road to Recovery 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 3Health News:Radio Interview Opportunity: Important News for Seniors 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 3Health News:Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3
... RPR kits use carbon particles coated ... which will combine with antibody present ... particles are suspended in a medium ... specific reactions. Positive reactions are shown ...
... The BD Macro-Vue RPR (Rapid ... and Tear-drop Tests are nontreponemal testing ... syphilis described in A Manual of ... in this manual are the most ...
Rapid Plasma Reagin (RPR) set is a non-treponemal flocculation test that is,used for the qualitative and semi-quantitative determination of reagin,antibodies in serum or plasma from persons with syph...
For use as a quality assurance reagent in assays detecting IgG antibody to mumps virus (mumps IgG), IgG antibody to measles (Rubeola) virus (measles IgG) and IgG antibody to varicella zoster virus (V...
Medicine Products: